Boston, MA, April 26, 2017 --(PR.com
)-- Soft tissues are body tissues that are not hardened or calcified, this includes tendon, muscle, skin, fat, and fascia. They typically connect, support, or surround bone and internal organs. Injury to soft tissue can be caused either due to sudden trauma or due to overuse of a particular part of the body. The soft tissue repair treatment is dependent on the type of injury and severity. Minor injuries are recovered on their own or with the use of mild treatment methods such as RICE that is rest, ice, compression and elevation. While, other severe injuries or conditions such as hernia, valve stenosis, third degree burns, ligament tears, etc., may require surgical repairs. As estimated by IQ4I Research, the soft tissue repair global market is expected to grow at CAGR of a high end single digit to reach $21,319.7 million by 2023.
Ageing is associated with a decline in muscle mass, strength, number of muscle fibres, changes in muscle contraction and slowing of nerve fibers that activate muscle making them prone to soft tissue injuries. Patients who experience extended immobility, as in the case of obese population, and ones who are at risk for developing chronic wounds or tissue damage, will increase the number of potential patients and thereby increase the number of medical procedures to repair the tissue damages. With substantial reduction in communicable diseases and advancements that are helping in preventing communicable diseases, the world is witnessing a shift towards lifestyle diseases such as cardiovascular diseases and injuries due to recreational sports activities. There has been an explosion in cardiovascular diseases (CVDs) that has reached alarming proportions. Along with these factors, increase in healthcare expenditure and growing emerging markets across the globe is driving the soft tissue repair market.
The soft tissue global market is segmented into products, surgery, applications and geography. The products market is further divided into meshes/tissue patches, fixation devices, cardiac repair devices and others. The cardiac repair devices segment accounted largest share, due to technological advancements, increasing awareness, etc.
Based on the surgery, the soft tissue repair global market is segmented into open surgery and minimally invasive surgery. Although, open surgery is the traditional form of most surgeries, minimally invasive surgeries are taking over the market in the case of soft tissue repair. Minimally invasive surgery thus accounts for the largest share in this segment.
Soft tissue repair global market is classified by application into hernia repair, dental reconstruction, vaginal sling procedures, skin repair, breast reconstruction, orthopedic, cardiac repair, and others. Cardiac repair segment accounted for the largest share, as aged population who are prone to cardiovascular diseases such as cardiac valve stenosis, aneurysm and other cardiac related problems are expected to rise. Skin repair is the fastest growing segment due to increased awareness especially in cases such as diabetic foot ulcers and treatment options.
The soft tissue repair global market based on geography is divided into North America, Europe, Asia-Pacific and Rest of the world. North America region commanded the largest revenue market share. However, Asia- Pacific region is expected to grow at the highest due to rising awareness, higher economic growth, large patient pool and rising aged population.
The soft tissue repair market is consolidated because the majority of the soft tissue repair market is occupied by players such as Edwards Lifesciences, Abbott Laboratories, Arthrex Inc, Medtronic PLC, and Allergan (Lifecell).
Major players in soft tissue repair market include Edwards Lifesciences (U.S.), Medtronic PLC (Ireland), Abbott Laboratories (U.S.), Arthrex Inc (U.S.), Johnson & Johnson (U.S.), C.R. Bard Inc, (U.S.), Allergan (Lifecell) (U.S.), Smith & Nephew (U.K.), Integra Lifesciences (U.S.), Livanova (U.K.), Zimmer Biomet (U.S.), Organogenesis (U.S.), etc.
Some of the other companies operating in soft tissue repair global market include, Abiss (Switzerland), Admedus (Australia), Advanced Medical Solutions Group PLC (U.K.), Angiologica BM Srl (Italy), Aroa (New Zealand), Aspide Medical (France), B.Braun (Germany), Braile bio medica (Brazil), Betatech Medical (Turkey), Changzhou DAHUA Corp., Ltd (China), Coloplast (Denmark), Inion Oy (Finland), Kerecis (Iceland), Lotus Surgical Pvt Ltd (India), Novus Scientific (Singapore), Occlutech (Sweden), S & G Biotech, Inc. (South Korea), Strait Access Technologies Pty Ltd (South Africa), Valcare Medical (Israel), Medtentia International Ltd Oy (Finland), etc.